Understanding analytical methods: what each result can tell you

A laboratory report becomes easier to read when you give every result a specific job. One line may address the identity of the submitted material. Another may describe the proportion of a chromatographic signal. A third may estimate how much of a defined substance is present. Those are separate questions, even when they appear together beside one product name.

Start by writing the question you want answered. Then locate the result, method and reporting basis that address it. This guide explains that reading process; the companion COA guide walks through the document field by field.

Begin with the quantity or property being measured

The scientific term measurand means the quantity intended to be measured. NIST explains why both its numerical value and its reference matter: a measurement needs a clear statement of what the number describes. Before comparing reports, identify the material, property, unit and basis attached to each result. NIST: measurement uncertainty and the measurand.

Use this reading map to keep your notes precise:

Treat an unanswered field as a question to resolve. Do not silently turn a missing result into zero, or a method name into a result that the report never gives.

HPLC separates components before a detector measures a signal

Chromatography separates components through their different distributions between a stationary phase and a moving phase. HPLC is a form of liquid chromatography. A chromatogram presents the detector response across the separation, so its peaks belong to a particular analytical method and detection arrangement. IUPAC Gold Book: chromatography.

When a report includes a chromatogram, read the axes before the headline percentage. Look for the detector description, the peak assigned to the target, the integration table and any explanatory notes. If only a cropped image is available, request the complete report rather than estimating a result from the picture.

Retention time can help compare a sample with a reference under defined conditions, but a matching time alone is limited identity evidence. ICH Q6A explicitly cautions against identification based solely on a single chromatographic retention time and discusses combinations of measurements that improve discrimination. Q6A concerns pharmaceutical specifications; that principle helps explain the limitation without establishing that a research material meets those specifications. ICH Q6A, section 3.2.1(b), hosted by FDA.

For your notes, prefer a sentence such as “the report assigns this peak to the target using the stated method.” Keep a separate line for the evidence supporting that assignment. This makes it easier to see whether the document supplies a reference comparison, another analytical result, or only a label.

An area percentage needs its denominator

Consider a deliberately simplified reading example: a peak contributes 990 units of integrated area, and the sum of the included peak areas is 1,000 units. The resulting area proportion is 99%. The calculation describes those included signals. Nothing in that arithmetic establishes the total mass of material in a container.

Mass fraction has a different denominator: the mass of a component relative to the total mass of the mixture. Converting between a signal proportion and a mass-based result requires an appropriate measurement approach; the word “percent” alone does not identify which quantity was determined. IUPAC Gold Book: mass fraction.

Peptide purity assignment can therefore involve more than one measurement. A NIST-associated study using angiotensin I examined mass balance, impurity-corrected amino acid analysis, elemental analysis and quantitative NMR for assigning a purity mass fraction. It is a useful example of how the analytical question determines the evidence needed. It does not make the findings for that calibrator transferable to a different peptide or lot. Josephs and colleagues, 2018, publication record and DOI.

When reading “purity,” ask which components the method addresses and how the reported percentage was calculated. Keep water, counterions and other possible constituents as explicit questions when their treatment is unclear, rather than assuming they are included in a chromatographic result.

Mass spectrometry adds a different kind of evidence

A mass spectrum reports signals associated with ions. The familiar horizontal-axis notation m/z refers to mass-to-charge information; the charge assignment matters when relating an observed signal to a proposed molecular species. Copy the reported ion assignment and calculated comparison value together, rather than recording a bare number as “the mass.” IUPAC Gold Book: mass-to-charge ratio.

A matching mass is one piece of structural evidence. Tandem mass spectrometry can add information from fragmentation patterns. NIST’s peptide spectral libraries contain annotated reference spectra used to support comparison and peptide identification. The existence of such a library is not evidence that a particular report performed a library match or established an entire sequence. NIST: Standard Reference Database 1C.

Read the claim at the level the report supports. “Observed signal is consistent with the expected ion” and “sequence supported by interpreted fragmentation data” describe different amounts of information. If the document says only “MS,” ask what measurement and interpretation that abbreviation covers. For names, sequence conventions and structural differences that a simple label can miss, continue to compound identity.

Quantity requires a stated measurement approach

Look for an actual quantity result before interpreting a nominal label amount. Record the unit exactly, together with what was measured. A concentration in a submitted solution, a mass fraction in a solid, and a quantity assigned to a container require different statements of the measurement basis.

Several methods can contribute to peptide quantification. A collaborative study reported through NIST compared HPLC assay, quantitative NMR and amino acid analysis for oxytocin. Its HPLC discussion distinguishes an assay against an external standard from a general chromatographic purity figure. The study concerns the suitability and reproducibility of those approaches for its chosen material; it is not a universal ranking of instruments. Li and colleagues, 2019, peptide quantification study.

A useful question for the laboratory is: “What was the reference or calibration basis for this quantity result?” NIST describes metrological traceability as a property of a measurement result connected to a reference through documented calibrations, with uncertainty contributions along that chain. A mention of a reference standard is a starting point for checking that connection, not a substitute for the documentation. NIST: metrological traceability.

Read validation terms as evidence about a defined purpose

ICH Q2(R2) describes validation as demonstrating that an analytical procedure is suitable for its intended purpose. Relevant characteristics include specificity or selectivity, accuracy, precision and the range over which a result can be reported. The guideline addresses procedures used in pharmaceutical development and control; citing its vocabulary does not certify a laboratory, material or commercial claim. ICH Q2(R2), sections 1 to 3, current EMA-hosted text.

Translate those terms into questions about the actual report. Can the procedure distinguish the target from plausible interference? How was agreement with a reference assessed? How variable were repeated results? Is the reported result inside the demonstrated range? “Validated” becomes informative when the document identifies the procedure and the use for which its performance was established.

Detection and quantitation also answer different questions. A detection limit concerns recognizing a signal or presence at a low level; a quantitation limit concerns measuring an amount with suitable performance. A statement below a reporting limit should retain that limit and qualifier when you summarize it. It should not become an unqualified claim of absence. ICH Q2(R2), glossary and lower-range-limit discussion.

Keep the sample and the uncertainty in view

The 2025 Eurachem method-validation guide includes sampling and sample handling because the analytical process reaches beyond the instrument. For a reader, that means preserving the distinction between the submitted sample and a broader batch claim. Ask what was sampled, how that sample was identified, and which material the conclusion actually covers. Eurachem: The Fitness for Purpose of Analytical Methods, third edition.

Where uncertainty is reported, keep its stated form and interpretation alongside the value. NIST explains that uncertainty describes the spread of values that can reasonably be associated with a measurement, using the available information. Extra decimal places do not by themselves explain that uncertainty. NIST: measurement uncertainty.

Finish with a compact record: sample identifier; question asked; method; result and unit; comparison or calibration basis; stated limits; unresolved questions. That record gives you a reliable route back to the original document. Use the same habit when moving from laboratory records to reading a research paper: preserve what was measured before interpreting what it might mean.